Document is current
Any future updates will be listed below
-
Authors
Vaccarin, Christian
Beyer, Darja
Schmid, Jerome V.
Klein, Bastian
Jegathasan, Jathursa
Behera, Shreshtha
Deupi, Xavier
Schibli, Roger
Müller, Cristina https://orcid.org/0000-0001-9357-9688
-
Funding
Funding for this research was provided by:
PSI - Paul Scherrer Institute
- License Information
-
More Information
Article History
Received: 6 August 2025
Accepted: 19 September 2025
First Online: 27 October 2025
Declarations
:
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. In particular, all animal experiments were carried out according to the guidelines of the Swiss Regulations for Animal Welfare. The preclinical studies have been ethically approved by the Cantonal Committee of Animal Experimentation and permitted by the responsible cantonal authorities (License N° 75721). The studies were carried out in compliance with the ARRIVE guidelines for reporting of research involving animals.
: The Paul Scherrer Institute has filed a patent with regard to albumin-binding uPAR radiopeptides. C. Müller, R. Schibli, C. Vaccarin and D. Beyer are listed as co-inventors on the patent application.
